Compare MREO & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MREO | QUCY |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United Kingdom | Germany |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 48.8M |
| IPO Year | 2017 | 2021 |
| Metric | MREO | QUCY |
|---|---|---|
| Price | $0.30 | $2.04 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | 4.2M | ★ 41.7M |
| Earning Date | 05-11-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $5,184.20 | $74.34 |
| Revenue Next Year | $55.51 | $171.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.30 |
| 52 Week High | $2.94 | $4.93 |
| Indicator | MREO | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 49.55 |
| Support Level | $0.22 | $0.38 |
| Resistance Level | $0.36 | $4.93 |
| Average True Range (ATR) | 0.04 | 0.45 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 45.09 | 6.31 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.